查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1776198

切片機的全球市場 - 市場考察，競爭情形，市場預測(2032年)

Microtome - Market Insights, Competitive Landscape, and Market Forecast - 2032
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

預計 2025 年至 2032 年期間，全球切片機市場將以 6.13% 的複合年增長率成長。切片機的需求主要源自於慢性疾病發生率的上升，例如癌症、傳染病、心血管疾病（例如動脈粥狀硬化、心肌梗塞和心肌病變）以及呼吸系統疾病（例如氣喘和慢性阻塞性肺病 (COPD)）。此外，全球生物醫學研究和藥物開發活動的不斷擴展也推動了切片機的需求。研究人員對用於分子診斷、藥物研發和個人化醫療的高品質組織切片的需求，將在預測期內（2025-2032 年）推動切片機市場的發展。

切片機市場動態

根據國際癌症研究機構 (2024) 提供的數據，2022 年全球新增癌症病例約 2,000 萬例。該機構還報告稱，在這些新增癌症病例中，肺癌最為常見，全球新增病例達 250 萬例；其次是乳腺癌，新增病例達 230 萬例；結直腸癌，新增病例達 190 萬例；胃腸癌，新增病例達 97 萬例。

全球癌症觀察組織 (2024) 估計，到 2030 年，全球將新增 2,000 萬至 2,410 萬例癌症病例。此外，預計新增癌症病例的地區包括亞洲（9,826,539 例）、歐洲（4,471,422 例）、拉丁美洲和加勒比地區（1,551,060 例）以及非洲（1,185,216 例）。

癌症的診斷和治療在很大程度上依賴準確的組織檢查。隨著癌症發生率的上升，切片機越來越普遍地用於製備高品質的組織切片以進行顯微分析。癌症患者數量的快速成長推動了切片機市場的擴張。

此外，在結核病、肝炎、新冠肺炎 (COVID-19) 和真菌感染等傳染病爆發期間，對活檢組織進行組織病理學評估對於識別病原體、評估組織損傷程度和監測病情進展至關重要。根據世界衛生組織 (WHO) 提供的數據，預計到 2023 年，全球將有 1,080 萬人感染結核病，其中包括 600 萬名男性、360 萬名女性和 130 萬名兒童。此外，根據相同來源估計，到2022年，全球將有2.54億人感染B肝，5,000萬人感染C肝，每天新增6,000例病毒性肝炎病例。切片機對於製作薄而均勻的組織切片至關重要，這些切片可在顯微鏡下染色和檢查以進行確診，從而推動整個切片機市場的發展。

因此，預計所有上述因素都將在預測期內推動切片機市場的發展。

然而，冷凍切片和雷射顯微切割等替代樣品製備技術的出現，可能會減少對傳統切片機的依賴，從而限制最終用戶群，並抑制預測期內切片機市場的成長。

預計北美將主導整個切片機市場。

預計到2024年，北美將在所有地區中佔據切片機市場的最大佔有率。這是由於北美癌症患者和傳染病患者的持續成長。此外，高端醫療基礎設施和現有的高科技設備、先進癌症診斷檢測和篩檢的前景不斷擴大、病理實驗室的優惠報銷政策、不斷上漲的醫療成本以及該地區眾多市場參與者的存在，預計將推動北美切片機市場的成長。

美國國家癌症研究所（2024）估計，到2024年底，美國將診斷出200萬例新發癌症病例。此外，攝護腺癌、肺癌和大腸癌估計約佔男性所有癌症診斷的48%。乳癌、肺癌和大腸癌是最常見的癌症，預計將佔所有新診斷癌症的 51% 左右。

本報告研究並分析了全球切片機市場，提供了市場規模和預測、過去三年產品/技術發展、主要市場參與者以及可用機會等資訊。

目錄

第1章 切片機市場報告的簡介

第2章 切片機市場摘要整理

  • 市場概要

第3章 競爭情形

第4章 法規分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第5章 切片機市場主要原因的分析

  • 切片機市場促進因素
  • 切片機市場阻礙因素與課題
  • 切片機市場機會

第6章 切片機市場波特的五力分析

第7章 切片機市場評估

  • 各產品
    • 設備
    • 配件
  • 各技術
    • 全自動
    • 半自動
    • 手動
  • 各終端用戶
    • 醫院
    • 診斷診所
    • 學術研究所
    • 其他
  • 地區
    • 北美
    • 歐洲
    • 亞太地區
    • 其他地區

第8章 切片機市場企業與產品的簡介

  • Thermo Fisher Scientific Inc
  • AGD Biomedicals Pvt. Ltd.
  • SLEE medical GmbH
  • Diapath S.p.A.
  • Leica Biosystems Nussloch GmbH
  • Green Leaf Scientific
  • MEDITE Medical GmbH
  • LLS ROWIAK LaserLabSolutions GmbH
  • Amos Scientific PTY. LTD
  • RWD Life Science Co
  • Sakura Finetek
  • Boeckeler Instruments, Inc.
  • HACKER Instruments & Industries Inc
  • microTec Laborgerate GmbH
  • Bright Instrument Co Limited.
  • JINHUA YIDI MEDICAL APPLIANCES CO., LTD
  • FEATHER Safety Razor Co., Ltd
  • Precisionary Instruments
  • Powered Milestone S.r.l.
  • Weinkauf Medizintechnik

第9章 KOL的見解

第10章 計劃方法

第11章 關於DelveInsight

第12章 免責聲明，諮詢方式

Product Code: DIMDCL0751

Microtome Market by Product (Microtome [Rotary Microtome, Vibrating Microtome, and Others] and Accessories [Blades and Knives, Cooling Clamp, and Others]), Technology (Fully Automated, Semi-Automated, and Manual), End-User (Hospitals, Diagnostic Clinics, Academic and Research Laboratories, and Others), and Geography (North America, Europe, Asia-Pacific, and rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the growing cases of chronic disorders, increase in research and development activities, among others globally.

The microtome market is estimated to grow at a CAGR of 6.13% during the forecast period from 2025 to 2032. The demand for microtomes is primarily being boosted by the increasing cases of chronic disorders such as cancer, infectious disease, cardiovascular diseases, including atherosclerosis, myocardial infarction, and cardiomyopathies, respiratory disorders like asthma, chronic obstructive pulmonary disease (COPD), and others. Additionally, the expansion of biomedical research and pharmaceutical development activities worldwide is fueling the demand for microtomes. Researchers require high-quality tissue sections for molecular diagnostics, drug discovery, and personalized medicine, thus boosting the market for microtomes during the forecast period from 2025 to 2032.

Microtome Market Dynamics:

According to data provided by the International Agency for Research on Cancer (2024), in 2022, approximately 20 million new instances of cancer were registered globally. Additionally, as per the same source, lung cancer accounted for 2.5 million new cases globally, of all the registered new cancer cases, making it the most common cancer. Next in order of incidence were breast cancer with 2.3 million cases, colon cancer with 1.9 million cases, and stomach cancer with 0.97 million cases globally.

The Global Cancer Observatory (2024) estimated that the new instances of cancer globally would range from 20 million to 24.1 million by the year 2030. Moreover, it stated that Asia accounted for 9,826,539 cancer cases, Europe accounted for 4,471,422 cancer cases, LAC accounted for 1,551,060 cancer cases, and Africa accounted for 1,185,216 cancer cases.

Since cancer diagnosis and treatment rely heavily on accurate tissue examination, the rising cancer rates necessitate the widespread use of microtomes to prepare high-quality tissue sections for microscopic analysis. This surge in cancer cases translates into a larger market for microtomes.

Additionally, during outbreaks of infectious diseases such as tuberculosis, hepatitis, COVID-19, and fungal infections, histopathological evaluation of biopsied tissues becomes essential to identify the pathogen, assess the extent of tissue damage, and monitor disease progression. According to the data provided by the World Health Organization, in 2023, an estimated 10.8 million people fell ill with TB worldwide, including 6.0 million men, 3.6 million women, and 1.3 million children. Additionally, as per the same source, in 2022, an estimated 254 million people were living with hepatitis B and 50 million people were living with hepatitis C worldwide, and 6000 people were newly infected with viral hepatitis each day. Microtomes are crucial in preparing thin, uniform tissue sections that are stained and examined under microscopes for definitive diagnosis, thereby boosting the overall market of microtomes.

Therefore, all the above-mentioned factors are expected to drive the market for microtomes during the given forecast period.

However, the availability of alternative sample preparation technologies, such as cryo-sectioning and laser microdissection, could reduce the reliance on traditional microtomes, acting as factors that are expected to limit their end-user base, thus restricting the growth of the microtome market during the forecast period.

Microtome Market Segment Analysis:

Microtome Market by Product (Microtome [Rotary Microtome, Vibrating Microtome, and Others] and Accessories [Blades and Knives, Cooling Clamp, and Others]), Technology (Fully Automated, Semi-Automated, and Manual), End-User (Hospital, Diagnostic Clinics, Academic and Research Laboratories, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the technology segment of the microtome market, the fully automated category of microtome is estimated to amass a significant revenue share in the microtome market in 2024. This can be attributed to the large patient population associated with various chronic disorders and the presence of a variety of products available to this category.

Fully automated microtomes offer several advantages and diverse applications, significantly enhancing the field of histopathology. Their primary benefits are to produce consistent high quality tissue sections with minimal user intervention, ensuring precision and reproducibility. This automation reduces the risk of human error and variability, which is crucial for accurate diagnosis.

In terms of applications, fully automated microtomes are invaluable in cancer diagnostics, where they provide fine tissue sections needed for detailed examination of tumor morphology and margins. They are also extensively used in research settings to study disease mechanisms at the cellular level, contributing to the development of new treatments and therapies. These advanced instruments are employed in various medical fields, including neuropathology, dermatopathology, and cardiovascular pathology, where precise tissue sectioning is critical for studying complex structures and diagnosing conditions.

Additionally, the presence of a huge number of commercially available fully automated systems and the increasing demand for digitalization in tissue diagnostic procedures are some of the crucial factors anticipated to boost the market in the next few years. Some of the key automated products include Microtome A550, Tissue-Tek Genie, and Leica Biosystems HistoCore AUTOCUT 2550.

Therefore, the various advantages and applications provided by fully automated microtomes will contribute to the growth of this category, thereby driving the growth of the overall microtome market during the forecast period.

North America is expected to dominate the overall microtome market:

North America is expected to account for the highest proportion of the microtome market in 2024, out of all regions. This is owing to the continual increase in cancer cases and infectious diseases in the North America region. Moreover, the high-end medical infrastructure paired with readily available high-tech equipment, expanding prospects for sophisticated cancer diagnostic testing and screening, favorable reimbursement policies for pathology labs, rise in healthcare spending, presence of a large number of market players in the region are expected to drive the growth of the microtome market in North America.

The National Cancer Institute (2024) estimated that 2 million new cases of cancer will be diagnosed in the US by the end of 2024. Furthermore, it was estimated that prostate, lung, and colorectal cancers were expected to represent approximately 48% of all cancer diagnoses in men. The most prevalent cancers are breast, lung, and colorectal, which are expected to account for about 51% of all new cancer diagnoses.

According to Global Cancer Observatory's data (2024), in 2022, the US represented 89.1% of all cancer cases, and Canada represented 10.9% of all cancer cases. The reliance on microtomes for accurate tissue sectioning in cancer diagnosis and research is paramount. Microtomes are essential for producing high-quality tissue samples for identifying cancer types, understanding disease progression, and tailoring treatment plans. Consequently, the rising instances of cancer catalyze the demand for microtomes, hence propelling market growth.

According to the recently updated data provided by the Centers for Disease Control and Prevention (CDC) (2024), it was stated that 805,000 people in the US have a myocardial infarction (heart attack) every year on average. The high incidence of myocardial infarctions necessitates extensive histological examination of cardiac tissues to understand the underlying causes. Microtomes are essential in preparing thin, detailed sections of heart tissue for microscopic analysis, enabling pathologists to examine cellular structures, detect abnormalities, and evaluate the effectiveness of treatment, therefore boosting its market growth.

According to the American Lung Association data updated in April 2024, it stated that more than 34 million people were living in the US with chronic lung diseases like asthma and COPD. These disorders underscore the growing need for microtomes in diagnostic pathology because of their ability to produce high-quality lung tissue sections for microscopic analysis, which is vital for diagnosing, understanding, and treating these conditions, consequently boosting the market for microtomes.

Thus, due to the interplay of all the above-mentioned factors, it will lead to an increase in the North America microtome market growth during the forecast period from 2025 to 2032.

Microtome Market Key Players:

Some of the key market players operating in the microtome market include Thermo Fisher Scientific Inc., AGD Biomedicals Pvt. Ltd., SLEE medical GmbH, Diapath S.p.A., Leica Biosystems Nussloch GmbH, Green Leaf Scientific, MEDITE Medical GmbH, LLS ROWIAK LaserLabSolutions GmbH, Amos Scientific PTY. LTD, RWD Life Science Co., Sakura Finetek, Boeckeler Instruments, Inc., HACKER Instruments & Industries Inc., microTec Laborgerate GmbH, Bright Instrument Co Limited, JINHUA YIDI MEDICAL APPLIANCES CO., LTD, FEATHER Safety Razor Co., Ltd., Precisionary Instruments, Powered Milestone Srl, Weinkauf Medizintechnik, and others.

Recent Developmental Activities in the Microtome Market:

  • In February 2023, Precisionary Instruments launched a brand new line of rotatory microtomes and offered 3 models for the same; RF-600: Manual model, RF-800: Semi-automated model, RF-1000: Fully automated model.

Key takeaways from the microtome market report study

  • Market size analysis for current microtome market size (2024), and market forecast over 8 years (2025 to 2032)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the global microtome market
  • Various opportunities available for the other competitors in the microtome market space.
  • What are the top-performing segments in 2024? How these segments will perform in 2032?
  • Which are the top-performing regions and countries in the current microtome market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for microtome market growth in the future?

Target audience who can benefit from this microtome market report study

  • Microtome product providers
  • Research organizations and consulting companies
  • Microtome-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in microtomes
  • Various end-users who want to know more about the microtome market and the latest technological developments in the microtome market.

Frequently Asked Questions for the Microtome Market:

1. What is a microtome?

  • Microtomes are specialized devices designed to create thin, uniform sections of tissue or other samples, typically ranging from a few micrometers to tens of micrometers in thickness.

2. What is the market for microtomes?

  • The microtome market is estimated to grow at a CAGR of 6.13% during the forecast period from 2025 to 2032.

3. What are the drivers for the global microtome market?

  • The microtome market is primarily being boosted by the increasing cases of chronic disorders such as cancer, infectious diseases, cardiovascular diseases, including atherosclerosis, myocardial infarction, and cardiomyopathies, respiratory disorders like asthma, chronic obstructive pulmonary disease (COPD), among others. Additionally, the expansion of biomedical research and pharmaceutical development activities worldwide is fueling the demand for microtomes. Researchers require high-quality tissue sections for molecular diagnostics, drug discovery, and personalized medicine, thus boosting the market for microtomes during the forecast period from 2025 to 2032.

4. Who are the key players operating in the microtome market?

  • Some of the key market players operating in microtome include Thermo Fisher Scientific Inc., AGD Biomedicals Pvt. Ltd., SLEE medical GmbH, Diapath S.p.A., Leica Biosystems Nussloch GmbH, Green Leaf Scientific, MEDITE Medical GmbH, LLS ROWIAK LaserLabSolutions GmbH, Amos Scientific PTY. LTD, RWD Life Science Co, Sakura Finetek, Boeckeler Instruments, Inc., HACKER Instruments & Industries Inc., microTec Laborgerate GmbH, Bright Instrument Co Limited, JINHUA YIDI MEDICAL APPLIANCES CO., LTD, FEATHER Safety Razor Co., Ltd., Precisionary Instruments, Powered Milestone Srl, Weinkauf Medizintechnik, and others.

5. Which region has the highest share in the microtome market?

  • North America is expected to account for the highest proportion of the microtome market in 2024, out of all regions. This is owing to the continual increase in cancer cases and infectious diseases in the North America region. Moreover, the high-end medical infrastructure paired with readily available high-tech equipment, expanding prospects for sophisticated cancer diagnostic testing and screening, favorable reimbursement policies for pathology labs, a rise in healthcare spending, presence of a large number of market players in the region are expected to drive the growth of the microtome market in North America.

Table of Contents

1. Microtome Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Microtome Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Microtome Market Key Factors Analysis

  • 5.1. Microtome Market Drivers
    • 5.1.1. Growing cases of chronic disorders
    • 5.1.2. Rise in research and development activities
  • 5.2. Microtome Market Restraints and Challenges
    • 5.2.1. Availability of alternative sample preparation technologies, such as cryo-sectioning and laser microdissection
  • 5.3. Microtome Market Opportunities
    • 5.3.1. Development of AI-integrated microtomes for efficiency, fewer human errors, and better reproducibility in tissue sectioning

6. Microtome Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Microtome Market Assessment

  • 7.1. By Product
    • 7.1.1. Devices
      • 7.1.1.1. Rotary Microtome
      • 7.1.1.2. Vibrating Microtome
      • 7.1.1.3. Others
    • 7.1.2. Accessories
      • 7.1.2.1. Blades and Knives
      • 7.1.2.2. Cooling Clamp
      • 7.1.2.3. Others
  • 7.2. By Technology
    • 7.2.1. Fully Automated
    • 7.2.2. Semi-Automated
    • 7.2.3. Manual
  • 7.3. By End-User
    • 7.3.1. Hospitals
    • 7.3.2. Diagnostic Clinics
    • 7.3.3. Academic and Research Laboratories
    • 7.3.4. Others
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. United States Microtome Market Size in USD million (2022-2032)
      • 7.4.1.2. Canada Microtome Market Size in USD million (2022-2032)
      • 7.4.1.3. Mexico Microtome Market Size in USD million (2022-2032)
    • 7.4.2. Europe
      • 7.4.2.1. France Microtome Market Size in USD million (2022-2032)
      • 7.4.2.2. Germany Microtome Market Size in USD million (2022-2032)
      • 7.4.2.3. United Kingdom Microtome Market Size in USD million (2022-2032)
      • 7.4.2.4. Italy Microtome Market Size in USD million (2022-2032)
      • 7.4.2.5. Spain Microtome Market Size in USD million (2022-2032)
      • 7.4.2.6. Rest of Europe Microtome Market Size in USD million (2022-2032)
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. China Microtome Market Size in USD million (2022-2032)
      • 7.4.3.2. Japan Microtome Market Size in USD million (2022-2032)
      • 7.4.3.3. India Microtome Market Size in USD million (2022-2032)
      • 7.4.3.4. Australia Microtome Market Size in USD million (2022-2032)
      • 7.4.3.5. South Korea Microtome Market Size in USD million (2022-2032)
      • 7.4.3.6. Rest of Asia-Pacific Microtome Market Size in USD million (2022-2032)
    • 7.4.4. Rest of the World (RoW)

8. Microtome Market Company and Product Profiles

  • 8.1. Thermo Fisher Scientific Inc
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. AGD Biomedicals Pvt. Ltd.
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. SLEE medical GmbH
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Diapath S.p.A.
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Leica Biosystems Nussloch GmbH
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Green Leaf Scientific
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. MEDITE Medical GmbH
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. LLS ROWIAK LaserLabSolutions GmbH
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Amos Scientific PTY. LTD
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. RWD Life Science Co
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Sakura Finetek
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Boeckeler Instruments, Inc.
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. HACKER Instruments & Industries Inc
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. microTec Laborgerate GmbH
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Bright Instrument Co Limited.
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. JINHUA YIDI MEDICAL APPLIANCES CO., LTD
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. FEATHER Safety Razor Co., Ltd
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. Precisionary Instruments
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. Powered Milestone S.r.l.
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. Weinkauf Medizintechnik
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Microtome Market in Global (2022-2032)
  • Table 3: Microtome Market in Global by Product (2022-2032)
  • Table 4: Microtome Market in Global by Technology (2022-2032)
  • Table 5: Microtome Market in Global by End-User (2022-2032)
  • Table 6: Microtome Market in Global by Geography (2022-2032)
  • Table 7: Microtome Market in North America (2022-2032)
  • Table 8: Microtome Market in the United States (2022-2032)
  • Table 9: Microtome Market in Canada (2022-2032)
  • Table 10: Microtome Market in Mexico (2022-2032)
  • Table 11: Microtome Market in Europe (2022-2032)
  • Table 12: Microtome Market in France (2022-2032)
  • Table 13: Microtome Market in Germany (2022-2032)
  • Table 14: Microtome Market in United Kingdom (2022-2032)
  • Table 15: Microtome Market in Italy (2022-2032)
  • Table 16: Microtome Market in Spain (2022-2032)
  • Table 17: Microtome Market in the Rest of Europe (2022-2032)
  • Table 18: Microtome Market in Asia-Pacific (2022-2032)
  • Table 19: Microtome Market in China (2022-2032)
  • Table 20: Microtome Market in Japan (2022-2032)
  • Table 21: Microtome Market in India (2022-2032)
  • Table 22: Microtome Market in Australia (2022-2032)
  • Table 23: Microtome Market in South Korea (2022-2032)
  • Table 24: Microtome Market in Rest of Asia-Pacific (2022-2032)
  • Table 25: Microtome Market in the Rest of the World (2022-2032)
  • Table 26: Microtome Market in the Middle East (2022-2032)
  • Table 27: Microtome Market in Africa (2022-2032)
  • Table 28: Microtome Market in South America (2022-2032)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Microtome Market in Global (2022-2032)
  • Figure 3: Microtome Market in Global by Product (2022-2032)
  • Figure 4: Microtome Market in Global by Technology (2022-2032)
  • Figure 5: Microtome Market in Global by End-User (2022-2032)
  • Figure 6: Microtome Market in Global by Geography (2022-2032)
  • Figure 7: Microtome Market in North America (2022-2032)
  • Figure 8: Microtome Market in the United States (2022-2032)
  • Figure 9: Microtome Market in Canada (2022-2032)
  • Figure 10: Microtome Market in Mexico (2022-2032)
  • Figure 11: Microtome Market in Europe (2022-2032)
  • Figure 12: Microtome Market in France (2022-2032)
  • Figure 13: Microtome Market in Germany (2022-2032)
  • Figure 14: Microtome Market in the United Kingdom (2022-2032)
  • Figure 15: Microtome Market in Italy (2022-2032)
  • Figure 16: Microtome Market in Spain (2022-2032)
  • Figure 17: Microtome Market in the Rest of Europe (2022-2032)
  • Figure 18: Microtome Market in Asia-Pacific (2022-2032)
  • Figure 19: Microtome Market in China (2022-2032)
  • Figure 20: Microtome Market in Japan (2022-2032)
  • Figure 21: Microtome Market in India (2022-2032)
  • Figure 22: Microtome Market in Australia (2022-2032)
  • Figure 23: Microtome Market in South Korea (2022-2032)
  • Figure 24: Microtome Market in Rest of Asia-Pacific (2022-2032)
  • Figure 25: Microtome Market in the Rest of the World (2022-2032)
  • Figure 26: Microtome Market in the Middle East (2022-2032)
  • Figure 27: Microtome Market in Africa (2022-2032)
  • Figure 28: Microtome Market in South America (2022-2032)
  • Figure 29: Market Drivers
  • Figure 30: Market Barriers
  • Figure 31: Marker Opportunities
  • Figure 32: PORTER'S Five Force Analysis